Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Break Through Cancer Pilot Study Testing the Feasibility and Safety of Therapeutic Intervention for Patients With High-risk Clonal Cytopenia of Undetermined Significance (CCUS)

NCT06802146 is registered in ClinicalTrials.gov with Lachelle D. Weeks, MD, PhD as lead sponsor.

NCT NCT06802146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06802146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Break Through Cancer Pilot Study Testing the Feasibility and Safety of Therapeutic Intervention for Patients With High-risk Clonal Cytopenia of Undetermined Significance (CCUS)
Lead sponsor
Lachelle D. Weeks, MD, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
February 7, 2025
Completion date
December 1, 2028
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clonal cytopenia of undetermined significance, cytopenia